NCT06086366 Presynaptic Imaging in Major Depressive Episodes After COVID-19 Status RECRUITING Phase N/A
NCT06080646 Reward Processing and Depressive Subtypes: Identifying Neural Biotypes Status RECRUITING Phase N/A
NCT06076317 Relevance of a Telemedicine Monitoring in the Management of Depression Status RECRUITING Phase NA
NCT06072898 A Randomized Neuroimaging Trial of Psilocybin in Depression Status RECRUITING Phase PHASE2
NCT06058039 Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive Disorder Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06058013 Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06050070 Targeting Large-scale Networks in Depression With Real-time Functional Magnetic Resonance Imaging (fMRI) Neurofeedback Status RECRUITING Phase NA
NCT06043401 Tracking Brain Biomarkers and Renormalization Associated With Antidepressant Transcranial Magnetic Stimulation Therapy Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06029439 Study to Assess the Safety and Effectiveness of NMRA-335140-501 Status RECRUITING Phase PHASE3
NCT06029426 Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT06027177 Personalized, Predictive, Precise & Preventive Medicine for Major Depression Status UNKNOWN Phase N/A
NCT06026917 Assessing Dopamine Transporter Occupancy in the Patients With Depression Brain With Toludesvenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET) Status UNKNOWN Phase PHASE4
NCT06013384 Low-Intensity Focused Ultrasound for Treatment-Resistant Depression Status SUSPENDED Phase NA
NCT06011577 Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDD Status TERMINATED Phase PHASE3